Save your place

Sign in to WhoBought

Please try again later.

Anavex Life Sciences Corp. (AVXL) institutional ownership

Latest close $2.40 Jul 24, 2026
Market cap$805M 52-week range SectorHealthcare
Funds holding · Q1 2026
180
reported AVXL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
107 buyers · 73 sellers

Anavex Life Sciences Corp. (AVXL) price and institutional activity

Dates

Q1 2026

$0 bought by 107 investors
Two Sigma Investments, LPHrt Financial LP +105 more
$0 sold by 73 investors
Two Sigma Advisers, LPNwam LLC +71 more
Bought Sold Totals per quarter; hover a bar for the names.

Anavex Life Sciences Corp. (AVXL) institutional activity · 180

Investor Type Est. change Change Δ Own Date
Two Sigma Investments, LP · Added
Change +1.6M Δ Own +96.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.6M +96.4% Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.2M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.2M −100.0% Q1 2026
Nwam LLC · Exited
Change −871K Δ Own −100.0% Date Q1 2026
Nwam LLC Exited· Q1 2026 −871K −100.0% Q1 2026
Hrt Financial LP · New
Change +658K Date Q1 2026
Hrt Financial LP New· Q1 2026 +658K Q1 2026
AQR Capital Management LLC · Added
Change +607K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +607K Q1 2026
Susquehanna International Group, LLP · Added
Change +556K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +556K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +446K +391.9% Q1 2026
Qube Research & Technologies Ltd · Exited
Change −389K Δ Own −100.0% Date Q1 2026
Qube Research & Technologies Ltd Exited· Q1 2026 −389K −100.0% Q1 2026
Caption Management, LLC · Exited
Change −355K Δ Own −100.0% Date Q1 2026
Caption Management, LLC Exited· Q1 2026 −355K −100.0% Q1 2026
Bank of America Corp · Added
Change +339K Date Q1 2026
Bank of America Corp Added· Q1 2026 +339K Q1 2026
National Bank of Canada · Reduced
Change −304K Date Q1 2026
National Bank of Canada Reduced· Q1 2026 −304K Q1 2026
Vanguard · Added
Change +300K Date Q1 2026
Vanguard Added· Q1 2026 +300K Q1 2026
Point72 Asset Management, L.P. · Exited
Change −278K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −278K −100.0% Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +251K +988.8% Q1 2026
Marshall Wace, LLP · Added
Change +237K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +237K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 180

Famous investor activity in Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Corp. (AVXL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Missling Christopher U. · Director, Officer Grant (A) 125K
Owned 125K Trade date Jan 6, 2026 Filed date Jan 9, 2026
Missling Christopher U. Director, Officer Grant (A) 125K 125K Jan 6, 2026 Jan 9, 2026
Boenisch Sandra · Officer Grant (A) 12K
Owned 12K Trade date Jan 6, 2026 Filed date Jan 9, 2026
Boenisch Sandra Officer Grant (A) 12K 12K Jan 6, 2026 Jan 9, 2026
Boenisch Sandra · Officer Grant (A) 12K
Owned 25K Trade date Oct 2, 2025 Filed date Oct 3, 2025
Boenisch Sandra Officer Grant (A) 12K 25K Oct 2, 2025 Oct 3, 2025
Missling Christopher U. · Director, Officer Grant (A) 125K
Owned 250K Trade date Oct 2, 2025 Filed date Oct 3, 2025
Missling Christopher U. Director, Officer Grant (A) 125K 250K Oct 2, 2025 Oct 3, 2025
Missling Christopher U. · Director, Officer 2 operations 0
Price $5.04 Owned 0 Trade date Sep 11, 2025 Filed date Sep 12, 2025
Missling Christopher U. Director, Officer 2 operations $5.04 0 0 Sep 11, 2025 Sep 12, 2025
Missling Christopher U. · Director, Officer Tax withholding or exercise payment (F) -$1.4M
Price $9.58 Qty -145K Owned 1.5M Trade date Sep 11, 2025 Filed date Sep 12, 2025
Missling Christopher U. Director, Officer Tax withholding or exercise payment (F) $9.58 -145K -$1.4M 1.5M Sep 11, 2025 Sep 12, 2025
Boenisch Sandra · Officer Grant (A) 12K
Owned 12K Trade date Aug 20, 2025 Filed date Aug 22, 2025
Boenisch Sandra Officer Grant (A) 12K 12K Aug 20, 2025 Aug 22, 2025
Missling Christopher U. · Director, Officer Grant (A) 125K
Owned 125K Trade date Aug 20, 2025 Filed date Aug 22, 2025
Missling Christopher U. Director, Officer Grant (A) 125K 125K Aug 20, 2025 Aug 22, 2025
8 of 8

Anavex Life Sciences Corp. (AVXL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 6.7M
% of shares outstanding 8.1% Filing date Jan 25, 2024
BlackRock Inc. 6.7M 8.1% Jan 25, 2024
Vanguard Group Inc 4.4M
% of shares outstanding 5.3% Filing date Feb 13, 2024
Vanguard Group Inc 4.4M 5.3% Feb 13, 2024
State Street Corp
% of shares outstanding 4.4% Filing date Jan 22, 2024
State Street Corp 4.4% Jan 22, 2024
Vanguard Group Inc 0
% of shares outstanding 0.0% Filing date Mar 26, 2026
Vanguard Group Inc 0 0.0% Mar 26, 2026
4 of 4

Anavex Life Sciences Corp. (AVXL) ownership FAQ

Who owns AVXL?

180 reporting institutions disclosed AVXL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.